Recall Z-0814-2022— Cytocell Ltd.
Class III · Terminated
Class III FDA medical device recall by Cytocell Ltd., initiated 2022-02-04, terminated 2024-11-06. Product: TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA sequences upon chromosome Catalog Number: LPH046-A. Reason: May show unexpected locus specific signals in addition to those at 14q32..
- Recalling firm
- Cytocell Ltd.
- Classification
- Class III
- Status
- Terminated
- Initiated
- 2022-02-04
- Terminated
- 2024-11-06
- Firm location
- Cambridge, N/A, United Kingdom
Product description
TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA sequences upon chromosome Catalog Number: LPH046-A
Reason for recall
May show unexpected locus specific signals in addition to those at 14q32.
Data sourced from openFDA. This site is unofficial and independent of the FDA.